case_images: PMC10913505_01
case_images: Patient's clinical course (months 0-16). The relationships among the BNT162b2 mRNA Coronavirus Disease 2019 (COVID-19) vaccine, symptoms severity, laboratory data, and treatment are shown. Eight months after the first dose of the BNT162b2 mRNA COVID-19 vaccine, polymyalgia rheumatica promptly disappeared.
case_images: 10.1177_2050313X241235830-fig1.jpg
case_images: PMC10913505_01_10.1177_2050313X241235830-fig1.jpg
case_images: fig1-2050313X241235830